Atlas Trials

Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome

Clinical trial NCT00002800 · COMPLETED

Trial details

NCT number
NCT00002800
Sponsor
Memorial Sloan Kettering Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
LeukemiaMyelodysplastic SyndromesNeutropenia
Start date
1996-07-01
Primary completion
2003-03-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.